The incidence of atypical fractures associated with prolonged bisphosphonate therapy has increased because of widespread use for treatment of osteoporosis. They can occur following a minimal or no trauma andpresents as thigh or groin pain. Because of the atypical presentation of these fractures, they may go unnoticed for weeks to months before presenting with a completed femoral fracture. So it's important to keep the overall balance of risks and benefits of bisphosphonate therapy. For some people, the benefits of the bisphosphonate therapies far outweigh the risks involved. The purpose of this article is to highlight the clinico-radiological features leading to early detection and management of such atypical fractures